Brain Sciences (Jul 2024)

Dopamine Dysregulation in Reward and Autism Spectrum Disorder

  • Kenneth Blum,
  • Abdalla Bowirrat,
  • Keerthy Sunder,
  • Panayotis K. Thanos,
  • Colin Hanna,
  • Mark S. Gold,
  • Catherine A. Dennen,
  • Igor Elman,
  • Kevin T. Murphy,
  • Milan T. Makale

DOI
https://doi.org/10.3390/brainsci14070733
Journal volume & issue
Vol. 14, no. 7
p. 733

Abstract

Read online

Autism spectrum disorder (ASD) is primarily characterized by core deficits in social skills, communication, and cognition and by repetitive stereotyped behaviors. These manifestations are variable between individuals, and ASD pathogenesis is complex, with over a thousand implicated genes, many epigenetic factors, and multiple environmental influences. The mesolimbic dopamine (DA) mediated brain reward system is held to play a key role, but the rapidly expanding literature reveals intricate, nuanced signaling involving a wide array of mesolimbic loci, neurotransmitters and receptor subtypes, and neuronal variants. How altered DA signaling may constitute a downstream convergence of the manifold causal origins of ASD is not well understood. A clear working framework of ASD pathogenesis may help delineate common stages and potential diagnostic and interventional opportunities. Hence, we summarize the known natural history of ASD in the context of emerging data and perspectives to update ASD reward signaling. Then, against this backdrop, we proffer a provisional framework that organizes ASD pathogenesis into successive levels, including (1) genetic and epigenetic changes, (2) disrupted mesolimbic reward signaling pathways, (3) dysregulated neurotransmitter/DA signaling, and finally, (4) altered neurocognitive and social behavior and possible antagonist/agonist based ASD interventions. This subdivision of ASD into a logical progression of potentially addressable parts may help facilitate the rational formulation of diagnostics and targeted treatments.

Keywords